Zimmer Biomet Holdings (ZBH) Asset Writedowns and Impairment (2009 - 2022)

Zimmer Biomet Holdings' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $289.8 million for Q4 2022.

• On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $289.8 million in Q4 2022; TTM through Dec 2022 was $292.8 million, a 332.94% increase from a year earlier, with the FY2022 full-year figure at $292.8 million, up 1696.32% from the prior year.
• Asset Writedowns and Impairment grew to $289.8 million in Q4 2022 per ZBH's latest filing, from $3.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $975.9 million in Q4 2018 and bottomed at -$142.0 million in Q4 2020.
• The 5-year median for Asset Writedowns and Impairment is $33.0 million (2020), against an average of $206.9 million.
• Biggest YoY gain for Asset Writedowns and Impairment was 258.79% in 2018; the steepest drop was 88.38% in 2018.
• Year by year, Asset Writedowns and Impairment stood at $975.9 million in 2018, then plunged by 92.82% to $70.1 million in 2019, then sank by 302.57% to -$142.0 million in 2020, then soared by 111.48% to $16.3 million in 2021, then surged by 1677.91% to $289.8 million in 2022.
• Per Business Quant, the three latest ZBH Asset Writedowns and Impairment figures stand at $289.8 million (Q4 2022), $3.0 million (Q2 2022), and $16.3 million (Q2 2021).